SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Matinas BioPharma Holdings, Inc. (MTNB)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Apr. 28, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 28, 2025 CORRESP Neutral/Informational Moderate Matinas BioPharma Holdings, Inc. has submitted a request to the SEC to declare their Registration Statement on Form S-3 effective by April 29, 2025. This request is made in accord… Read Filing EDGAR
Apr. 28, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated April 28, 2025, informs Jerome D. Jabbour, CEO of Matinas BioPharma Holdings, Inc., that the SEC has not reviewed and will not review their registrati… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.